ATE46718T1 - Hybride menschliche leukozyten-interferone, verfahren zu deren mikrobieller herstellung, zwischenverbindungen dafuer und dieselben enthaltende zusammensetzungen. - Google Patents
Hybride menschliche leukozyten-interferone, verfahren zu deren mikrobieller herstellung, zwischenverbindungen dafuer und dieselben enthaltende zusammensetzungen.Info
- Publication number
- ATE46718T1 ATE46718T1 AT81109579T AT81109579T ATE46718T1 AT E46718 T1 ATE46718 T1 AT E46718T1 AT 81109579 T AT81109579 T AT 81109579T AT 81109579 T AT81109579 T AT 81109579T AT E46718 T1 ATE46718 T1 AT E46718T1
- Authority
- AT
- Austria
- Prior art keywords
- interferons
- processes
- same
- hybrid human
- compositions containing
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title abstract 4
- 108010050904 Interferons Proteins 0.000 title abstract 4
- 229940047124 interferons Drugs 0.000 title abstract 4
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000013598 vector Substances 0.000 abstract 2
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20557980A | 1980-11-10 | 1980-11-10 | |
| US06/237,388 US4414150A (en) | 1980-11-10 | 1981-02-23 | Hybrid human leukocyte interferons |
| US06/305,657 US4456748A (en) | 1981-02-23 | 1981-09-25 | Hybrid human leukocyte interferons |
| EP81109579A EP0051873B1 (de) | 1980-11-10 | 1981-11-09 | Hybride menschliche Leukozyten-Interferone, Verfahren zu deren mikrobieller Herstellung, Zwischenverbindungen dafür und dieselben enthaltende Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE46718T1 true ATE46718T1 (de) | 1989-10-15 |
Family
ID=27394813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT81109579T ATE46718T1 (de) | 1980-11-10 | 1981-11-09 | Hybride menschliche leukozyten-interferone, verfahren zu deren mikrobieller herstellung, zwischenverbindungen dafuer und dieselben enthaltende zusammensetzungen. |
Country Status (34)
| Country | Link |
|---|---|
| EP (1) | EP0051873B1 (de) |
| JP (1) | JP2642291B2 (de) |
| KR (1) | KR920007439B1 (de) |
| AT (1) | ATE46718T1 (de) |
| AU (1) | AU555293B2 (de) |
| BR (1) | BR8107293A (de) |
| CA (2) | CA1212915A (de) |
| CH (2) | CH660743A5 (de) |
| DE (2) | DE3144469A1 (de) |
| DK (1) | DK173590B1 (de) |
| DO (1) | DOP1981004064A (de) |
| DZ (1) | DZ350A1 (de) |
| ES (2) | ES506955A0 (de) |
| FI (1) | FI79550C (de) |
| FR (1) | FR2493867B1 (de) |
| GB (1) | GB2090258B (de) |
| GR (1) | GR81947B (de) |
| HK (1) | HK51685A (de) |
| IE (1) | IE51850B1 (de) |
| IL (1) | IL64243A (de) |
| IT (1) | IT1169276B (de) |
| KE (1) | KE3536A (de) |
| LU (1) | LU83745A1 (de) |
| MC (1) | MC1424A1 (de) |
| MY (2) | MY8700710A (de) |
| NL (1) | NL189092C (de) |
| NO (1) | NO165201C (de) |
| NZ (1) | NZ198906A (de) |
| PH (1) | PH18565A (de) |
| PL (1) | PL233748A1 (de) |
| PT (1) | PT73955B (de) |
| SE (1) | SE460539B (de) |
| YU (1) | YU46597B (de) |
| ZW (1) | ZW26981A1 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH651308A5 (de) * | 1980-07-01 | 1985-09-13 | Hoffmann La Roche | Interferone und deren herstellung. |
| EP0085693A1 (de) * | 1981-08-14 | 1983-08-17 | A/S Alfred Benzon | Gegenstände betreffend menschliche interferon-alpha-subtyp-eiweissstoffe sowie übereinstimmende antikörper |
| EP0072541A3 (de) * | 1981-08-14 | 1984-04-18 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Menschliche Leukozyten-Interferone, Verfahren zu deren Mikrobiologischer Herstellung, Zwischenprodukte und diese enthaltende Zusammensetzungen |
| GB2108510B (en) * | 1981-10-03 | 1984-12-12 | Ciba Geigy Ag | Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof |
| IT1167610B (it) * | 1982-01-19 | 1987-05-13 | Cetus Corp | Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione |
| DE3220116A1 (de) * | 1982-05-28 | 1983-12-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung |
| IE56509B1 (en) * | 1982-11-04 | 1991-08-28 | Univ California | Methods for oncogenic detection |
| US4751287A (en) * | 1983-02-24 | 1988-06-14 | Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr | Human leukocyte interferon N and a method of producing same in bacterial cells |
| GB8315980D0 (en) * | 1983-06-10 | 1983-07-13 | Biogen Nv | Producing hybrid dna sequences |
| GB8317880D0 (en) * | 1983-07-01 | 1983-08-03 | Searle & Co | Structure and synthesis of interferons |
| US4892743A (en) * | 1983-12-21 | 1990-01-09 | Schering Corporation | Novel hybrid interferon species |
| EP0146903A3 (de) * | 1983-12-19 | 1987-07-22 | Schering Corporation | Herstellung eines ein Hybrid-Interferon-Spezies kodierenden Vektors |
| DE3409966A1 (de) * | 1984-03-19 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens |
| JPS6156199A (ja) * | 1984-08-27 | 1986-03-20 | Shionogi & Co Ltd | 新規ヒトインタ−フエロンα類 |
| EP0173935A1 (de) * | 1984-08-31 | 1986-03-12 | University Patents, Inc. | Hybrid-Lymphoblastoid-Leukozyten-Humaninterferone |
| DE3434345A1 (de) * | 1984-09-19 | 1986-03-27 | Hoechst Ag, 6230 Frankfurt | Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen |
| EP0194006B1 (de) * | 1985-02-01 | 1992-04-29 | Imperial Chemical Industries Plc | Analoge Interferon-Polypeptide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
| DE3685996T2 (de) * | 1985-06-11 | 1993-01-14 | Ciba Geigy Ag | Hybrid-interferone. |
| WO1987002037A1 (en) * | 1985-09-26 | 1987-04-09 | Genetics Institute, Inc. | Pulmonary surfactant proteins |
| US4806347A (en) * | 1985-12-11 | 1989-02-21 | Schering Corporation | Interferon combinations |
| EP0490233A1 (de) * | 1986-03-10 | 1992-06-17 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE3607835A1 (de) * | 1986-03-10 | 1987-09-24 | Boehringer Ingelheim Int | Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung |
| US4851220A (en) * | 1986-11-26 | 1989-07-25 | Schering Corporation | Stable oleaginous gel |
| US4853218A (en) * | 1987-02-24 | 1989-08-01 | Schering Corporation | Zinc-protamine-alpha interferon complex |
| EP0331635A3 (de) * | 1988-02-29 | 1990-02-28 | The Board of Regents of the University of Texas System | Zubereitungen zur Behandlung von Blasenkrebs. |
| US5372808A (en) † | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
| GB2273931A (en) * | 1992-09-28 | 1994-07-06 | Unilever Plc | Mutant polypeptides |
| JPH11507352A (ja) | 1995-06-07 | 1999-06-29 | ジンタ・インコーポレイテッド | 新規カルバメート基本カチオン性脂質 |
| TW442492B (en) * | 1995-07-26 | 2001-06-23 | Novartis Ag | Process for the enrichment of interferon |
| FR2823220B1 (fr) | 2001-04-04 | 2003-12-12 | Genodyssee | Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo) |
| CA2498319A1 (en) | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| US7314613B2 (en) | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| CA2566247A1 (en) | 2004-05-19 | 2005-12-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| MX2007014524A (es) | 2005-05-18 | 2008-02-07 | Maxygen Inc | Polipeptidos desarrollados de interferon-alfa. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY1346A (en) * | 1980-01-08 | 1987-01-16 | Biogen Nv | Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides |
-
1981
- 1981-11-07 ES ES506955A patent/ES506955A0/es active Granted
- 1981-11-09 EP EP81109579A patent/EP0051873B1/de not_active Expired
- 1981-11-09 GR GR66464A patent/GR81947B/el unknown
- 1981-11-09 DE DE19813144469 patent/DE3144469A1/de not_active Ceased
- 1981-11-09 IL IL64243A patent/IL64243A/xx not_active IP Right Cessation
- 1981-11-09 MC MC811558A patent/MC1424A1/fr unknown
- 1981-11-09 DE DE8181109579T patent/DE3177106D1/de not_active Expired
- 1981-11-09 PT PT73955A patent/PT73955B/pt unknown
- 1981-11-09 CA CA000389688A patent/CA1212915A/en not_active Expired
- 1981-11-09 PL PL23374881A patent/PL233748A1/xx unknown
- 1981-11-09 IE IE2622/81A patent/IE51850B1/en not_active IP Right Cessation
- 1981-11-09 AU AU77304/81A patent/AU555293B2/en not_active Expired
- 1981-11-09 GB GB8133762A patent/GB2090258B/en not_active Expired
- 1981-11-09 CH CH7174/81A patent/CH660743A5/de not_active IP Right Cessation
- 1981-11-09 FR FR8120943A patent/FR2493867B1/fr not_active Expired
- 1981-11-09 DK DK198104946A patent/DK173590B1/da active
- 1981-11-09 NZ NZ198906A patent/NZ198906A/en unknown
- 1981-11-09 SE SE8106641A patent/SE460539B/sv not_active Application Discontinuation
- 1981-11-09 DZ DZ816369A patent/DZ350A1/fr active
- 1981-11-09 NO NO813785A patent/NO165201C/no not_active IP Right Cessation
- 1981-11-09 CH CH5574/85A patent/CH663032A5/de not_active IP Right Cessation
- 1981-11-09 PH PH26462A patent/PH18565A/en unknown
- 1981-11-09 AT AT81109579T patent/ATE46718T1/de not_active IP Right Cessation
- 1981-11-10 ZW ZW269/81A patent/ZW26981A1/xx unknown
- 1981-11-10 KR KR1019810004343A patent/KR920007439B1/ko not_active Expired
- 1981-11-10 YU YU265681A patent/YU46597B/sh unknown
- 1981-11-10 IT IT24967/81A patent/IT1169276B/it active
- 1981-11-10 LU LU83745A patent/LU83745A1/de unknown
- 1981-11-10 DO DO1981004064A patent/DOP1981004064A/es unknown
- 1981-11-10 FI FI813539A patent/FI79550C/fi not_active IP Right Cessation
- 1981-11-10 BR BR8107293A patent/BR8107293A/pt unknown
- 1981-11-10 NL NLAANVRAGE8105078,A patent/NL189092C/xx not_active IP Right Cessation
-
1982
- 1982-05-19 ES ES512354A patent/ES512354A0/es active Granted
-
1984
- 1984-12-18 CA CA000470467A patent/CA1277616C/en not_active Expired - Lifetime
-
1985
- 1985-05-21 KE KE3536A patent/KE3536A/xx unknown
- 1985-07-04 HK HK516/85A patent/HK51685A/xx not_active IP Right Cessation
-
1987
- 1987-12-30 MY MY710/87A patent/MY8700710A/xx unknown
-
1988
- 1988-12-30 MY MY66/88A patent/MY8800066A/xx unknown
-
1992
- 1992-12-28 JP JP4349148A patent/JP2642291B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3177106D1 (en) | Hybrid human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them | |
| SE8105657L (sv) | Mikrobiell framstellning av humanfibroblastinterferon | |
| HK49285A (en) | Interferons and process for their preparation | |
| DK1029870T3 (da) | Hybride immunglobuliner til anvendelse i terapeutiske fremgangsmåder | |
| DE69233045D1 (de) | Ribosomen inaktivierende proteine enthaltende materialien, verfahren zu ihrer herstellung und ihre verwendung | |
| ATE501254T1 (de) | P- selectin ligandenprotein | |
| DE3485336D1 (de) | Verfahren zur expression von alpha-1-antitrypsin in bakterien und dessen verwendung in therapeutischen zusammensetzungen sowie vektoren und bakterien fuer ein solches verfahren und deren herstellung. | |
| EP0072541A3 (de) | Menschliche Leukozyten-Interferone, Verfahren zu deren Mikrobiologischer Herstellung, Zwischenprodukte und diese enthaltende Zusammensetzungen | |
| DE3888386D1 (de) | Verfahren zur Herstellung von Proteinen. | |
| ATE47864T1 (de) | Verschiedenartige familie von menschlichen leukozyten-interferonen, zusammensetzungen, die diese enthalten, verfahren zu ihrer herstellung, sowie dna und transfektierte wirte hierfuer. | |
| EP0676413A3 (de) | Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |